Advertisement
Screener

GREENLAND MINES LTD (GRML) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

GREENLAND MINES LTD Cash Flow Breakdown

Cash flow breakdown shows where GREENLAND MINES LTD's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $5.89M went out.
  • Fiscal year ended 2025-12-31: from financing, $13.00M came in.
  • Fiscal year ended 2025-12-31: change in cash, $7.11M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingCommercial paperNew shares soldNot split outChange in cash
2025-12-31-$5.89M$1.11M$11.89M*$7.11M
2024-12-31-$2.95M-$123.50K$3.13M*$60.93K
2023-12-31-$446.92K$23.85K$100.00K-$73.06K
2022-12-31-$493.04K-$116.15M-$50.00K$25.00K$117.00M*$336.01K

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$6.85M*-$428.68K*$6.62M*
2026-03-31-$4.97M-$365.32K$7.75M$2.83M
2025-12-31-$1.28M*$1.11M*
2025-09-30-$1.12M*-$494.70K*
2025-06-30-$1.94M*$9.80M*
2025-03-31-$1.55M$2.06M*$502.13K
2024-12-31-$944.15K*$0.00*$957.00K*
2024-09-30-$1.07M*$0.00*
2024-06-30-$907.42K*-$1.00*$1.72M*
2024-03-31-$21.98K-$123.50K$175.00K$29.53K
2023-12-31-$199.51K*$100.18K*
2023-09-30$18.02K*-$56.33K*
2023-06-30$107.55K*$340.00K*
2023-03-31-$372.98K-$360.00K$510.00K*-$222.98K
2022-12-31-$73.18K*$0.00*$0.00*
2022-09-30-$33.24K*$0.00*$0.00*
2022-06-30-$392.91K*$0.00*$116.98M*
2022-03-31$6.29K$25.00K$1.72K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43